Literature DB >> 25252123

A five generation family with a novel mutation in FOXC2 and lymphedema worsening to hydrops in the youngest generation.

Carole Sargent1, Julien Bauer, Muhamed Khalil, Parker Filmore, Michael Bernas, Marlys Witte, M Peggy Pearson, Robert P Erickson.   

Abstract

We describe a five generation family with dominantly inherited lymphedema, but no distichiasis, in which 3/3 affected offspring in the fifth generation have died of fetal hydrops and related birth defects. Mutational analysis disclosed a novel mutation in FOXC2 (R121C) in affected members. We searched for possible genetic influences on the greater severity of lymphedema (hydrops) in the fifth generation. Karyotypes disclosed an extra band in Xp in one affected fetus, but this was also found in the mother. Copy number variation (CNV) studies on four members of the pedigree (mother of the three severely affected fetuses/infants; one severely affected; a full, and a half, unaffected sibs) did not detect the source of the Xp band or a possible influence on the severe phenotype. However, use of SNP arrays did allow identification of the portion of the maternal proximal Xp shared by a hydrops-affected daughter and son which was not shared by an unaffected daughter from the same sibship.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  FOXC2; Xp; fetal hydrops; lymphedema; lymphedema distichiasis

Mesh:

Substances:

Year:  2014        PMID: 25252123      PMCID: PMC4205179          DOI: 10.1002/ajmg.a.36736

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  24 in total

1.  Proteolytic processing of vascular endothelial growth factor-D is essential for its capacity to promote the growth and spread of cancer.

Authors:  Nicole C Harris; Karri Paavonen; Natalia Davydova; Sally Roufail; Teruhiko Sato; You-Fang Zhang; Tara Karnezis; Steven A Stacker; Marc G Achen
Journal:  FASEB J       Date:  2011-04-22       Impact factor: 5.191

2.  Therapy with siRNA for Vegf-c but not for Vegf-d suppresses wide-spectrum organ metastasis in an immunocompetent xenograft model of metastatic mammary cancer.

Authors:  Masa-Aki Shibata; Eiko Shibata; Junji Morimoto; Mariko Harada-Shiba
Journal:  Anticancer Res       Date:  2013-10       Impact factor: 2.480

3.  Increased production of vascular endothelial growth factor-d and lymphangiogenesis in acute Kawasaki disease.

Authors:  Ryota Ebata; Jun Abe; Kumi Yasukawa; Hiromichi Hamada; Kouji Higashi; Yasushi Suwazono; Hirohisa Saito; Masaru Terai; Yoichi Kohno
Journal:  Circ J       Date:  2011-04-12       Impact factor: 2.993

4.  Isolation of the mouse (MFH-1) and human (FKHL 14) mesenchyme fork head-1 genes reveals conservation of their gene and protein structures.

Authors:  N Miura; K Iida; H Kakinuma; X L Yang; T Sugiyama
Journal:  Genomics       Date:  1997-05-01       Impact factor: 5.736

5.  Breakpoint analysis of Turner patients with partial Xp deletions: implications for the lymphoedema gene location.

Authors:  C A Boucher; C A Sargent; T Ogata; N A Affara
Journal:  J Med Genet       Date:  2001-09       Impact factor: 6.318

6.  Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome.

Authors:  J Fang; S L Dagenais; R P Erickson; M F Arlt; M W Glynn; J L Gorski; L H Seaver; T W Glover
Journal:  Am J Hum Genet       Date:  2000-11-08       Impact factor: 11.025

7.  VEGF-D promotes the metastatic spread of tumor cells via the lymphatics.

Authors:  S A Stacker; C Caesar; M E Baldwin; G E Thornton; R A Williams; R Prevo; D G Jackson; S Nishikawa; H Kubo; M G Achen
Journal:  Nat Med       Date:  2001-02       Impact factor: 53.440

8.  Vascular endothelial growth factor-D is a key molecule that enhances lymphatic metastasis of soft tissue sarcomas.

Authors:  Takashi Yanagawa; Tetsuya Shinozaki; Hideomi Watanabe; Kenichi Saito; Avraham Raz; Kenji Takagishi
Journal:  Exp Cell Res       Date:  2012-02-03       Impact factor: 3.905

9.  Clustered arrangement of winged helix genes fkh-6 and MFH-1: possible implications for mesoderm development.

Authors:  K H Kaestner; S C Bleckmann; A P Monaghan; J Schlöndorff; A Mincheva; P Lichter; G Schütz
Journal:  Development       Date:  1996-06       Impact factor: 6.868

10.  VEGFD regulates blood vascular development by modulating SOX18 activity.

Authors:  Tam Duong; Katarzyna Koltowska; Cathy Pichol-Thievend; Ludovic Le Guen; Frank Fontaine; Kelly A Smith; Vy Truong; Renae Skoczylas; Steven A Stacker; Marc G Achen; Peter Koopman; Benjamin M Hogan; Mathias Francois
Journal:  Blood       Date:  2013-11-22       Impact factor: 22.113

View more
  2 in total

1.  Digenic Inheritance of a FOXC2 Mutation and Two PIEZO1 Mutations Underlies Congenital Lymphedema in a Multigeneration Family.

Authors:  Debbie J Mustacich; Li-Wen Lai; Michael J Bernas; Jazmine A Jones; Reginald J Myles; Phillip H Kuo; Walter H Williams; Charles L Witte; Robert P Erickson; Marlys Hearst Witte
Journal:  Am J Med       Date:  2021-10-15       Impact factor: 4.965

2.  Mechanisms of Connexin-Related Lymphedema.

Authors:  Jorge A Castorena-Gonzalez; Scott D Zawieja; Min Li; R Sathish Srinivasan; Alexander M Simon; Cor de Wit; Roger de la Torre; Luis A Martinez-Lemus; Grant W Hennig; Michael J Davis
Journal:  Circ Res       Date:  2018-09-28       Impact factor: 17.367

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.